Universities in The Netherlands are one of the best at doing research in the field of Life Sciences. They rank in the top 3 for most patents per capita in Europe. But the number of ideas that actually reach patients is much lower. Eline van Beest explains why this is the case, and offers ideas to improve this situation.

Credits and thanks to: Recording studio sponsor @ University of Applied Sciences Leiden. Graphic design by Esmé Postma, Ire Oyekan and Sheila Herron. Intro music Birds by Scandinavianz | https://soundcloud.com/scandinavianz Creative Commons Attribution 3.0 Unported License https://creativecommons.org/licenses/by/3.0/deed.en_US Eline Vrijland-van Beest is a healthcare innovator, venture partner and an expert in knowledge valorization. Currently, she is the CEO of Hybridize Therapeutics, a spin-off from the Leiden University Medical Center (LUMC) that develops RNA-based therapies for kidney diseases. Before, Eline founded NightBalance. A spin-off and MedTech scale-up from the Technical University of Delft focusing on a new therapy for sleep apnea which was acquired by Philips in 2018. Eline is also a Venture Partner at Thuja Capital, part of the Investment Committee of the Deep Tech Fund of Economic Affairs & InvestNL. She holds a position in the Investment Committee of the Graduate Entrepreneur Pre Seed Fund and is a member of the Supervisory Board of Livassured (a company that introduces a smart wearable that warns caretakers on epileptic seizures). This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at https://www.ted.com/tedx